Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-May-24 9:05 PM View:  | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Natera, Inc. (NTRA) | 29-Apr-24 | Market Sale (Planned) | 929 | $93.14 | $86,525.90 | (< 1%) 111.68K to 110.75K | (< 1%) |
| 01-May-24 9:05 PM View: | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Natera, Inc. (NTRA) | 29-Apr-24 | Market Sale (Planned) | 1,196 | $93.14 | $111,394.00 | (1%) 117.03K to 115.83K | (< 1%) |
| 01-May-24 9:05 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 29-Apr-24 | Market Sale (Planned) | 4,084 | $93.14 | $380,378.00 | (2%) 230.32K to 226.24K | (< 1%) |
| 01-May-24 9:05 PM View: | Rabinowitz Daniel SEC. AND CHIEF LEGAL OFFICER | Natera, Inc. (NTRA) | 29-Apr-24 | Market Sale (Planned) | 1,057 | $93.14 | $98,447.60 | (< 1%) 205.55K to 204.5K | (< 1%) |
| 01-May-24 9:05 PM View: | Brophy Michael Burkes Chief Financial Officer | Natera, Inc. (NTRA) | 29-Apr-24 | Market Sale (Planned) | 1,238 | $93.14 | $115,306.00 | (2%) 70.65K to 69.41K | (< 1%) |
| 30-Apr-24 8:35 PM View: | Rosenman Herm Director | Natera, Inc. (NTRA) | 26-Apr-24 | Grant | 732 | -- | -- | 1% 61.69K to 62.42K | |
| 30-Apr-24 8:35 PM View: | Chapman Rowan E Director | Natera, Inc. (NTRA) | 26-Apr-24 | Grant | 488 | -- | -- | 5% 9.37K to 9.86K | |
| 26-Apr-24 9:35 PM View: | Brophy Michael Burkes Chief Financial Officer | Natera, Inc. (NTRA) | 26-Apr-24 | Market Sale (Planned) | 751 | $92.00 | $69,092.00 | (1%) 71.4K to 70.65K | (2%) |
| 30-Apr-24 8:35 PM View: | Baynes Roy D. Director | Natera, Inc. (NTRA) | 26-Apr-24 | Grant | 169 | -- | -- | 1% 12.41K to 12.58K | |
| 30-Apr-24 8:35 PM View: | Healy James Director | Natera, Inc. (NTRA) | 26-Apr-24 | Grant | 210 | -- | -- | < 1% 1.59M to 1.59M | |
| 30-Apr-24 8:35 PM View: | Botha Roelof Director | Natera, Inc. (NTRA) | 26-Apr-24 | Grant | 766 | -- | -- | < 1% 1.31M to 1.31M | |
| 30-Apr-24 8:35 PM View: | Marcus Gail Boxer Director | Natera, Inc. (NTRA) | 26-Apr-24 | Grant | 488 | -- | -- | 2% 20.15K to 20.63K | |
| 26-Apr-24 9:35 PM View: | Brophy Michael Burkes Chief Financial Officer | Natera, Inc. (NTRA) | 25-Apr-24 | Market Sale (Planned) | 705 | $89.55 | $63,132.80 | (< 1%) 72.1K to 71.4K | (5%) |
| 26-Apr-24 9:35 PM View: | Sheena Jonathan Director | Natera, Inc. (NTRA) | 25-Apr-24 | Market Sale (Planned) | 1,000 | $89.55 | $89,550.00 | (< 1%) 460.53K to 459.53K | (5%) |
| 26-Apr-24 9:35 PM View: | Brophy Michael Burkes Chief Financial Officer | Natera, Inc. (NTRA) | 24-Apr-24 | Market Sale (Planned) | 937 | $93.00 | $87,140.20 | (1%) 73.04K to 72.1K | (< 1%) |
| 23-Apr-24 9:35 PM View: | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Natera, Inc. (NTRA) | 23-Apr-24 | Market Sale (Planned) | 522 | $91.38 | $47,699.90 | (< 1%) 112.2K to 111.68K | (3%) |
| 23-Apr-24 9:35 PM View: | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Natera, Inc. (NTRA) | 23-Apr-24 | Market Sale (Planned) | 531 | $91.38 | $48,522.40 | (< 1%) 117.56K to 117.03K | (3%) |
| 23-Apr-24 9:35 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 23-Apr-24 | Planned Option Sale | 2,552 | $91.38 | $233,200.00 | (1%) 232.87K to 230.32K | |
| 23-Apr-24 9:35 PM View: | Rabinowitz Daniel SEC. AND CHIEF LEGAL OFFICER | Natera, Inc. (NTRA) | 23-Apr-24 | Planned Option Sale | 787 | $91.38 | $71,915.40 | (< 1%) 206.34K to 205.55K | |
| 23-Apr-24 9:35 PM View: | Brophy Michael Burkes Chief Financial Officer | Natera, Inc. (NTRA) | 23-Apr-24 | Planned Option Sale | 1,523 | $91.38 | $139,171.00 | (2%) 74.56K to 73.04K | |
| 23-Apr-24 9:35 PM View: | Brophy Michael Burkes Chief Financial Officer | Natera, Inc. (NTRA) | 22-Apr-24 | Option Exercise | 1,250 | -- | -- | 2% 73.31K to 74.56K | |
| 23-Apr-24 9:35 PM View: | Brophy Michael Burkes Chief Financial Officer | Natera, Inc. (NTRA) | 21-Apr-24 | Option Exercise | 1,145 | -- | -- | 2% 72.17K to 73.31K | |
| 23-Apr-24 9:35 PM View: | Sheena Jonathan Director | Natera, Inc. (NTRA) | 21-Apr-24 | Option Exercise | 143 | -- | -- | < 1% 460.38K to 460.53K | |
| 23-Apr-24 9:35 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 21-Apr-24 | Option Exercise | 1,775 | -- | -- | < 1% 231.1K to 232.87K | |
| 23-Apr-24 9:35 PM View: | Rabinowitz Daniel SEC. AND CHIEF LEGAL OFFICER | Natera, Inc. (NTRA) | 21-Apr-24 | Option Exercise | 644 | -- | -- | < 1% 205.69K to 206.34K | |
| 23-Apr-24 9:35 PM View: | Sheena Jonathan Director | Natera, Inc. (NTRA) | 20-Apr-24 | Option Exercise | 190 | -- | -- | < 1% 460.19K to 460.38K | |
| 23-Apr-24 9:35 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 20-Apr-24 | Option Exercise | 3,386 | -- | -- | 1% 227.71K to 231.1K | |
| 23-Apr-24 9:35 PM View: | Rabinowitz Daniel SEC. AND CHIEF LEGAL OFFICER | Natera, Inc. (NTRA) | 20-Apr-24 | Option Exercise | 856 | -- | -- | < 1% 204.84K to 205.69K | |
| 23-Apr-24 9:35 PM View: | Brophy Michael Burkes Chief Financial Officer | Natera, Inc. (NTRA) | 20-Apr-24 | Option Exercise | 1,521 | -- | -- | 2% 70.65K to 72.17K | |
| 17-Apr-24 9:05 PM View: | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Natera, Inc. (NTRA) | 16-Apr-24 | Market Sale (Planned) | 80,000 | $90.82 | $7,265,650.00 | (40%) 197.56K to 117.56K | (3%) |
| 17-Apr-24 9:05 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 15-Apr-24 | Market Sale (Planned) | 6,816 | $93.13 | $634,797.00 | (3%) 234.53K to 227.71K | (< 1%) |
| 04-Apr-24 9:35 PM View: | Sheena Jonathan Director | Natera, Inc. (NTRA) | 03-Apr-24 | Market Sale (Planned) | 26,700 | $92.47 | $2,468,820.00 | (5%) 486.89K to 460.19K | (1%) |
| 04-Apr-24 9:35 PM View: | Brophy Michael Burkes Chief Financial Officer | Natera, Inc. (NTRA) | 02-Apr-24 | Market Sale (Planned) | 1,378 | $92.62 | $127,629.00 | (2%) 72.02K to 70.65K | (1%) |
| 29-Mar-24 9:35 PM View: | Sheena Jonathan Director | Natera, Inc. (NTRA) | 28-Mar-24 | Sale (Planned) | 1,000 | $90.13 | $90,130.00 | (< 1%) 487.89K to 486.89K | |
| 29-Mar-24 9:35 PM View: | Rabinowitz Daniel SEC. AND CHIEF LEGAL OFFICER | Natera, Inc. (NTRA) | 28-Mar-24 | Planned Option Sale | 743 | $90.42 | $67,178.90 | (< 1%) 205.58K to 204.84K | |
| 29-Mar-24 9:35 PM View: | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Natera, Inc. (NTRA) | 28-Mar-24 | Market Sale (Planned) | 707 | $90.42 | $63,924.00 | (< 1%) 198.27K to 197.56K | (4%) |
| 29-Mar-24 9:35 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 28-Mar-24 | Sale (Planned) | 2,662 | $90.42 | $240,687.00 | (1%) 237.19K to 234.53K | |
| 29-Mar-24 9:35 PM View: | Sheena Jonathan Director | Natera, Inc. (NTRA) | 28-Mar-24 | Planned Option Sale | 447 | $90.22 | $40,326.40 | (< 1%) 488.34K to 487.89K | |
| 29-Mar-24 9:35 PM View: | Brophy Michael Burkes Chief Financial Officer | Natera, Inc. (NTRA) | 28-Mar-24 | Planned Option Sale | 914 | $90.42 | $82,640.00 | (1%) 72.94K to 72.02K | |
| 29-Mar-24 9:35 PM View: | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Natera, Inc. (NTRA) | 28-Mar-24 | Market Sale (Planned) | 464 | $90.42 | $41,952.90 | (< 1%) 112.66K to 112.2K | (4%) |
| 29-Mar-24 9:35 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 27-Mar-24 | Option Exercise | 5,184 | -- | -- | 2% 232.0K to 237.19K | |
| 29-Mar-24 9:35 PM View: | Rabinowitz Daniel SEC. AND CHIEF LEGAL OFFICER | Natera, Inc. (NTRA) | 27-Mar-24 | Option Exercise | 1,364 | -- | -- | < 1% 204.22K to 205.58K | |
| 29-Mar-24 9:35 PM View: | Brophy Michael Burkes Chief Financial Officer | Natera, Inc. (NTRA) | 27-Mar-24 | Option Exercise | 2,292 | -- | -- | 3% 70.65K to 72.94K | |
| 29-Mar-24 9:35 PM View: | Sheena Jonathan Director | Natera, Inc. (NTRA) | 27-Mar-24 | Option Exercise | 447 | -- | -- | < 1% 487.89K to 488.34K | |
| 29-Mar-24 9:35 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 15-Mar-24 | Market Option Sale (Planned) | 5,184 | $89.02 | $461,485.00 | (2%) 282.91K to 277.73K | (5%) |
| 15-Mar-24 9:05 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 15-Mar-24 | Option Exercise | 68,270 | $19.37 | $1,322,410.00 | 23% 297.87K to 366.14K | |
| 15-Mar-24 9:05 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 15-Mar-24 | Planned Option Sale | 68,270 | $88.96 | $6,073,310.00 | (19%) 366.14K to 297.87K | |
| 15-Mar-24 9:05 PM View: | Botha Roelof Director | Natera, Inc. (NTRA) | 15-Mar-24 | Option Exercise | 19,924 | $42.17 | $840,197.00 | 2% 1.29M to 1.31M | |
| 29-Mar-24 9:35 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 15-Mar-24 | Market Sale (Planned) | 45,726 | $89.02 | $4,070,580.00 | (16%) 277.73K to 232.0K | (5%) |
| 15-Mar-24 9:05 PM View: | Chapman Steven Leonard CEO AND PRESIDENT Director | Natera, Inc. (NTRA) | 15-Mar-24 | Sale (Planned) | 14,953 | $88.96 | $1,330,220.00 | (5%) 297.87K to 282.91K |
